Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Clinical trial NCT05401110 · RECRUITING
Trial details
- NCT number
- NCT05401110
- Sponsor
- Karen Reckamp, MD, MS
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2028-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.